Insider Transactions in Q4 2021 at Aeglea Bio Therapeutics, Inc. (AGLE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2021
|
Armen Shanafelt Director |
BUY
Open market or private purchase
|
Direct |
14,685
+8.92%
|
$44,055
$3.65 P/Share
|
|
Dec 10
2021
|
Anthony G. Quinn President & CEO |
BUY
Open market or private purchase
|
Direct |
10,526
+3.1%
|
$31,578
$3.75 P/Share
|
|
Dec 10
2021
|
Armen Shanafelt Director |
BUY
Open market or private purchase
|
Direct |
13,516
+9.08%
|
$40,548
$3.65 P/Share
|
|
Dec 09
2021
|
Jonathan Alspaugh President and CFO |
BUY
Open market or private purchase
|
Direct |
50,000
+35.62%
|
$150,000
$3.72 P/Share
|
|
Dec 09
2021
|
Anthony G. Quinn President & CEO |
BUY
Open market or private purchase
|
Direct |
43,108
+11.93%
|
$129,324
$3.7 P/Share
|
|
Dec 09
2021
|
Armen Shanafelt Director |
BUY
Open market or private purchase
|
Direct |
121,799
+50.0%
|
$365,397
$3.67 P/Share
|